Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Draft SGR Repeal Bill Reworks Doc Incentives, Includes Imaging/ECG Appropriateness Criteria

This article was originally published in The Gray Sheet

Executive Summary

The Senate Finance Committee and House Ways & Means Committee circulated a discussion draft to replace the maligned Medicare sustainable growth rate formula for physician pay with a system that freezes base payments but offers value-based incentives. The bill also calls for mandatory use of appropriateness criteria for advanced imaging and electrocardiogram, and prior authorization in some cases.

You may also be interested in...



Obama Budget Seeks Prior-Authorization Ability For All Medicare Fee-For-Service Items

The administration’s March 4 budget request, repeats past attempts to expand prior-authorization requirements for power wheelchairs and advanced imaging, while also giving CMS the authority to institute prior-authorization for all Medicare fee-for-service items.

House Physician Pay Bill Cheaper Than Senate Version, But Lacks Extenders

A pair of late-January estimates by the Congressional Budget Office of SGR reform bills prices the Senate Finance committee’s SGR bill at $150.4 billion and the House Ways and Means Committee’s version at $121 billion, but the House bill lacks important Medicare and Medicaid extenders due to expire soon.

FDA Budget, Physician Payments On Tap For Congress In The New Year

Congress is on a tight schedule to approve federal appropriations bills for FDA and other agencies. It may also take up comprehensive physician payment reform bills that passed out of committees late in 2013, legislation that could have important implications for the device space. Also to look out for: a changing of the guard in the powerful Senate Finance Committee.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032558

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel